Word

MUNJOVI

Status

Registered

Status Code

700

Status Date

Tuesday, January 25, 2022

Serial Number

90261241

Registration Number

6625339

Registration Date

Tuesday, January 25, 2022

Mark Type

4000

Filing Date

Saturday, October 17, 2020

Published for Opposition

Tuesday, November 9, 2021

Trademark Owner History

INCYTE HOLDINGS CORPORATION -
MorphoSys AG - Original Registrant

Classifications

5 Pharmaceuticals and pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines; diagnostic preparations for medical purposes; biological substances for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; Biological preparations for medical purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis

42 Research and development in the pharmaceutical and biotechnology fields; research and development of medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research, clinical research in the field of antibodies and pharmaceuticals, and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies

Trademark Events

Jan 31, 2024

Automatic Update Of Assignment Of Ownership

Jan 25, 2022

Registered-Principal Register

Nov 9, 2021

Official Gazette Publication Confirmation E-Mailed

Nov 9, 2021

Published For Opposition

Oct 20, 2021

Notification Of Notice Of Publication E-Mailed

Oct 5, 2021

Approved For Pub - Principal Register

Sep 28, 2021

Teas/Email Correspondence Entered

Sep 28, 2021

Correspondence Received In Law Office

Sep 20, 2021

Teas Response To Office Action Received

Mar 26, 2021

Notification Of Non-Final Action E-Mailed

Mar 26, 2021

Non-Final Action E-Mailed

Mar 26, 2021

Non-Final Action Written

Mar 17, 2021

Assigned To Examiner

Mar 9, 2021

Preliminary/Voluntary Amendment - Entered

Mar 1, 2021

Assigned To Lie

Dec 4, 2020

New Application Office Supplied Data Entered

Nov 27, 2020

Teas Voluntary Amendment Received

Oct 21, 2020

New Application Entered